Work

Abstract CT115: Phase 1b open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in combination with sintilimab (anti-PD1) in patients with advanced microsatellite stable (MSS) colorectal,gastroesophageal or ovarian cancer

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct115

Authors: Mark Wong, Niall Tebbutt, Tim Price, Shehara Mendis, Rafid Al-Asady, Eugene Hsu, Darren Shafren, Oksana Zdanska, Jia Liu

Institutions: Westmead Hospital, Austin Hospital, Queen Elizabeth Hospital, St Vincent's Hospital Sydney, The Kinghorn Cancer Centre

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409822120

Cites:

Cited by:

Related to: 10